Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA
Withdrawn before enrolling · Phase 4
Conditions studied: Cholecystitis, Cholelithiasis, Obstructive Sleep Apnea
In brief
The objective of this study is to determine if IV acetaminophen administered intraoperatively can decrease the dose of narcotics required for adequate pain control and shorten recovery time in the PACU specifically in obese patients at risk for obstructive sleep apnea.
Key facts
- Study ID
- NCT02056678
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 0
- Starts
- 2014-02-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2016-11-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Obesity (BMI greater than or equal to 30)
- Symptoms of obstructive sleep apnea as determined by an OSA questionnaire patients will complete preoperatively
- Prior diagnosis of obstructive sleep apnea
- Undergoing laparoscopic cholecystectomy
- 18 years old or greater
You may not qualify if…
- Negative OSA questionnaire or recent negative workup
- Open cholecystectomy or conversion to open procedure intraoperatively
- Allergy to acetaminophen
- Severe hepatic dysfunction
- Pediatric patients
- Patients unable to consent for themselves
Where it is running
- University Health System — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.